We found that CAL-101 treatment resulted in a significant increase in the viral copy number in the tumor tissues at day 12 post-treatment, suggesting that IL-27 can delay the clearance of VVs during intravenous delivery by inducing the production of IL-10, thus allowing more viruses to reach the tumor tissue to exert antitumor effects. Here, IL10 is linked to neoplasm.